[Preclinic of the new molecules active on colorectal neoplasms]  .
Gebbia
N
N
Servizio di Chemioterapia, Policlinico Universitario, Palermo.
Martello
A
A
Bajardi
E
E
D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000737:chemistry / Q000627:therapeutic use*; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D005641:Tegafur / Q000737:chemistry / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D003841:Deoxycytidine; D005641:Tegafur; D000069287:Capecitabine; D002955:Leucovorin; D005472:Fluorouracil